Ross Jennens

10.4k total citations
45 papers, 624 citations indexed

About

Ross Jennens is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ross Jennens has authored 45 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Ross Jennens's work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (7 papers) and Glioma Diagnosis and Treatment (6 papers). Ross Jennens is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (7 papers) and Glioma Diagnosis and Treatment (6 papers). Ross Jennens collaborates with scholars based in Australia, United States and Italy. Ross Jennens's co-authors include Mark Rosenthal, Graham G. Giles, R. M. Fox, Peter Gibbs, Michael Jefford, Kathryn Field, Suzanne Kosmider, Michael Michael, Michael Green and David Ball and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and CHEST Journal.

In The Last Decade

Ross Jennens

45 papers receiving 605 citations

Peers

Countries citing papers authored by Ross Jennens

Since Specialization

Citations

This map shows the geographic impact of Ross Jennens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross Jennens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross Jennens more than expected).

Fields of papers citing papers by Ross Jennens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ross Jennens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross Jennens. The network helps show where Ross Jennens may publish in the future.

Co-authorship network of co-authors of Ross Jennens

This figure shows the co-authorship network connecting the top 25 collaborators of Ross Jennens. A scholar is included among the top collaborators of Ross Jennens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ross Jennens. Ross Jennens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutated KRASas a promising target in pancreas cancer: PURPLE registry data to inform real-world incidence and prognostic significance and to aid trial recruitment. 2024 ·Journal of Clinical Oncology ·Belinda Lee, (unknown), Daniel Croagh, Marion Harris, Benjamin Thomson, Michael Michael, Benjamin Loveday, Sue‐Anne McLachlan, Brett Knowles, Jeremy Shapiro, Rachel Wong, Adrian Fox, Ross Jennens, (unknown), Russell Hodgson, (unknown), Sumitra Ananda, (unknown), Shehara Mendis, Peter Gibbs	1
2	Dodecafluoropentane Emulsion as a Radiosensitizer in Glioblastoma Multiforme 2023 ·Cancer Research Communications ·Jason D. Lickliter, Jeremy Ruben, Ganessan Kichenadasse, Ross Jennens, (unknown), Ralph P. Mason, (unknown), (unknown), Evan C. Unger, Baldassarre Stea	7
3	SABRSeq: A Randomized Phase Ib Trial of SABR Sequencing with Pembrolizumab in Metastatic Non-Small Cell Lung Cancer (NSCLC) 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Shankar Siva, (unknown), Mathias Bressel, (unknown), (unknown), (unknown), Ross Jennens, Alesha Thai, Lavinia Tan, (unknown), Sarah‐Jane Dawson, Mark Shaw, (unknown), Paul J. Neeson, David Ball, Benjamin Solomon	4
4	Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registry 2022 ·European Journal of Cancer ·(unknown), Mark Tacey, Benjamin Thomson, Michael Michael, Rachel Wong, (unknown), Ross Jennens, (unknown), Sharon Pattison, Matthew Burge, (unknown), Mehrdad Nikfarjam, Sumitra Ananda, Lara Lipton, Peter Gibbs, Belinda Lee	19
5	Standard-Dose Osimertinib in EGFR-Mutated Non–Small-Cell Lung Adenocarcinoma With Leptomeningeal Disease 2021 ·JCO Precision Oncology ·(unknown), (unknown), Sagun Parakh, Steven Kao, Craig Lewis, Melvin Chin, Mark Voskoboynik, Malinda Itchins, Ross Jennens, A. Broad, (unknown), Benjamin Solomon	4
6	Initial experience of TAS-102 chemotherapy in Australian patients with Chemo-refractory metastatic colorectal cancer 2021 ·Current Problems in Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Rachel Wong, (unknown), Lucy Gately, (unknown), (unknown), Suzanne Kosmider, Jeanne Tie, (unknown), Justin Yeung, Ross Jennens, Belinda Lee, J McKendrick, Lyn‐li Lim, Adnan Khattak, Peter Gibbs	1
7	A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer 2021 ·Translational Lung Cancer Research ·(unknown), Paul J. Neeson, Thomas John, Stephen Barnett, Gerard G. Hanna, Alistair Miller, Ross Jennens, Shankar Siva	10
8	Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer 2020 ·European Journal of Cancer ·(unknown), Cherie Chiang, Ross Jennens, (unknown), Prudence A. Francis	4
9	KEYNOTE-189 study of pembrolizumab (pembro) plus pemetrexed (pem) and platinum vs placebo plus pem and platinum for untreated, metastatic, nonsquamous NSCLC: Does choice of platinum affect outcomes? 2018 ·Annals of Oncology ·Delvys Rodríguez‐Abreu, M.C. Garassino, Emilio Esteban, G. Speranza, (unknown), Manuel Dómine, Maximilian J. Hochmair, Steven Powell, Susanna Y. Cheng, (unknown), Nir Peled, Rita L. Hui, Martin Reck, Edward B. Garon, Michael Boyer, Francesco Grossi, Ross Jennens, Jiong Yang, M. Catherine Pietanza, S. Gadgeel	4
10	Phase Ib KEYNOTE-200: A study of an intravenously delivered oncolytic virus, coxsackievirus A21 in combination with pembrolizumab in advanced NSCLC and bladder cancer patients 2018 ·Annals of Oncology ·Charles M. Rudin, Hardev Pandha, Sumati Gupta, Matthew R. Zibelman, Wallace Akerley, Daphne Day, Andrew Hill, Rachel E. Sanborn, Steven O’Day, Timothy Clay, Gavin Wright, Ross Jennens, David E. Gerber, Jonathan E. Rosenberg, Christy Ralph, David C. Campbell, Brendan D. Curti, Emmett V. Schmidt, Mark Grose, Darren R. Shafren	15
11	P2.06-027 Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Metastatic Pleural Mesothelioma 2017 ·Journal of Thoracic Oncology ·Raffit Hassan, Ross Jennens, Jan P. van Meerbeeck, John Nemunaitis, George R. Blumenschein, Dean A. Fennell, Hedy L. Kindler, Silvia Novello, Annette O. Walter, Danila Serpico, Jonathan Siegel, (unknown), Barrett H. Childs, Cem Elbi	1
12	Chemotherapy Treatments for Metastatic Colorectal Cancer: Is Evidence-Based Medicine in Practice? 2008 ·Journal of Oncology Practice ·Kathryn Field, Suzanne Kosmider, Michael Jefford, Ross Jennens, Michael Green, Peter Gibbs	14
13	A Pilot Human Evaluation of a Formulation of Irinotecan and Hyaluronic Acid in 5-Fluorouracil-Refractory Metastatic Colorectal Cancer Patients 2008 ·Chemotherapy ·Peter Gibbs, Tracey J. Brown, Raymond Ng, Ross Jennens, (unknown), (unknown), Michael Michael, Richard M. Fox	28
14	Surveillance following treatment for colorectal cancer in Australia. Has best practice been adopted by medical oncologists? 2007 ·Internal Medicine Journal ·Suzanne Kosmider, Kathryn Field, Michael Jefford, Ross Jennens, Peter Gibbs	5
15	Increasing underrepresentation of elderly patients with advanced colorectal or non‐small‐cell lung cancer in chemotherapy trials 2006 ·Internal Medicine Journal ·Ross Jennens, Graham G. Giles, R. M. Fox	74
16	Phase II study of two-weekly temozolomide in patients with high-grade gliomas 2005 ·Journal of Clinical Neuroscience ·Shirley Wong, Mark Rosenthal, Anthony Dowling, Ross Jennens, (unknown), David M. Ashley, Lawrence Cher	12
17	Metastatic myoepithelioma of the breast 2004 ·ANZ Journal of Surgery ·Ross Jennens, Mark Rosenthal, Michael Gonzales	11
18	Complete radiological and metabolic response of metastatic renal cell carcinoma to SU5416 (semaxanib) in a patient with probable von Hippel-Lindau syndrome 2004 ·Urologic Oncology Seminars and Original Investigations ·Ross Jennens, Mark Rosenthal, Geoffrey J. Lindeman, Michael Michael	25
19	Comparison of neutropenia in a randomized, crossover trial of 3-, 6-, and 24-h infusions of paclitaxel 2003 ·Gynecologic Oncology ·Ross Jennens, Danny Rischin, K. Yuen, Guy C. Toner, Michael Millward	6
20	Outcome of patients admitted to the intensive care unit with newly diagnosed small cell lung cancer 2002 ·Lung Cancer ·Ross Jennens, Mark Rosenthal, Paul Mitchell, Jeffrey Presneill	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact